Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam · Delayed Price · Currency is VND 45,150
-400 (-0.88%)
At close: Nov 3, 2026
HOSE:DBD Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,889,939 | 1,865,380 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 | |
Revenue Growth | 3.10% | 7.98% | 4.59% | 6.24% | -0.24% | 23.99% |
Cost of Revenue | 1,025,327 | 981,001 | 894,975 | 853,250 | 787,170 | 935,939 |
Gross Profit | 864,612 | 884,379 | 832,573 | 798,520 | 767,652 | 622,566 |
Selling, General & Admin | 540,351 | 558,103 | 526,981 | 501,538 | 494,312 | 405,437 |
Operating Expenses | 540,351 | 558,103 | 526,981 | 501,538 | 494,312 | 405,437 |
Operating Income | 324,261 | 326,276 | 305,592 | 296,982 | 273,339 | 217,129 |
Interest Expense | -12,283 | -3,847 | -4,058 | -6,998 | -1,916 | -1,325 |
Interest & Investment Income | 6,399 | 20,036 | 11,605 | 11,635 | 8,733 | 5,137 |
Earnings From Equity Investments | 37,794 | 12,280 | 27,063 | 28,704 | 24,786 | 16,083 |
Currency Exchange Gain (Loss) | 272.44 | 2,644 | -947.49 | -482.96 | 354.16 | 733.11 |
Other Non Operating Income (Expenses) | 20,217 | -11,308 | -12,119 | -9,753 | -6,739 | -5,310 |
EBT Excluding Unusual Items | 376,661 | 346,082 | 327,136 | 320,086 | 298,558 | 232,448 |
Gain (Loss) on Sale of Investments | - | - | -2,000 | - | - | - |
Pretax Income | 376,661 | 346,082 | 325,136 | 320,086 | 298,558 | 232,448 |
Income Tax Expense | 62,065 | 54,142 | 49,954 | 51,031 | 55,003 | 43,324 |
Net Income | 314,596 | 291,940 | 275,182 | 269,055 | 243,555 | 189,124 |
Preferred Dividends & Other Adjustments | 40,918 | 40,918 | 38,525 | 37,668 | 34,098 | 26,477 |
Net Income to Common | 273,678 | 251,022 | 236,656 | 231,387 | 209,457 | 162,646 |
Net Income Growth | 8.02% | 6.07% | 2.28% | 10.47% | 28.78% | 17.08% |
Shares Outstanding (Basic) | - | 94 | 94 | 94 | 94 | 94 |
Shares Outstanding (Diluted) | - | 94 | 94 | 94 | 94 | 94 |
Shares Change | - | 0.34% | - | -0.00% | - | -0.07% |
EPS (Basic) | - | 2673.96 | 2529.63 | 2473.31 | 2238.88 | 1738.52 |
EPS (Diluted) | - | 2673.96 | 2529.63 | 2473.00 | 2238.88 | 1738.52 |
EPS Growth | - | 5.71% | 2.29% | 10.46% | 28.78% | 17.16% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -70,685 | 206,614 | 115,985 | 148,663 | 82,184 | 62,932 |
Free Cash Flow Per Share | - | 2200.91 | 1239.77 | 1589.06 | 878.47 | 672.68 |
Dividend Per Share | - | - | 2000.000 | - | 1600.000 | - |
Dividend Growth | - | - | - | - | 90.67% | - |
Gross Margin | 45.75% | 47.41% | 48.19% | 48.34% | 49.37% | 39.95% |
Operating Margin | 17.16% | 17.49% | 17.69% | 17.98% | 17.58% | 13.93% |
Profit Margin | 14.48% | 13.46% | 13.70% | 14.01% | 13.47% | 10.44% |
Free Cash Flow Margin | -3.74% | 11.08% | 6.71% | 9.00% | 5.29% | 4.04% |
EBITDA | 365,608 | 375,841 | 353,705 | 342,951 | 315,005 | 255,818 |
EBITDA Margin | 19.35% | 20.15% | 20.47% | 20.76% | 20.26% | 16.41% |
D&A For EBITDA | 41,347 | 49,565 | 48,112 | 45,970 | 41,665 | 38,689 |
EBIT | 324,261 | 326,276 | 305,592 | 296,982 | 273,339 | 217,129 |
EBIT Margin | 17.16% | 17.49% | 17.69% | 17.98% | 17.58% | 13.93% |
Effective Tax Rate | 16.48% | 15.64% | 15.36% | 15.94% | 18.42% | 18.64% |
Revenue as Reported | 1,889,939 | 1,865,380 | 1,727,548 | 1,651,770 | 1,554,821 | 1,558,504 |